Harvard Women's Health Watch

Large trial finds annual screening doesn't reduce deaths from ovarian cancer

Annual screening for ovarian cancer with the CA-125 blood test and transvaginal ultrasound (TVUS) does not reduce a woman’s risk of dying from the disease, according to the results of a large clinical trial sponsored by the National Cancer Institute.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »